FEBRILE ILLNESS, MALARIA TEST POSITIVITY, AND BREAKTHROUGH INFECTION AMONG CHILDREN UNDER FIVE DURING SEASONAL MALARIA CHEMOPREVENTION IN PLATEAU STATE, NIGERIA: A RETROSPECTIVE ANALYSIS OF ROUTINE HEALTH FACILITY DATA, 2024
International Journal of Biomedical Research and Innovations·
- DOI
- 10.66837/ijbri01/522//04
- PMID
- —
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Soft Print and Media Resources Limited
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Routine monitoring highlights persistent diagnostic confirmation rates alongside widespread intervention coverage, indicating a need for enhanced programmatic tracking and periodic efficacy assessments.
Structured evidence summary
Research question
The investigation aimed to characterize monthly variations in febrile presentations, diagnostic confirmation rates, and medication distribution volumes among young pediatric patients receiving seasonal malaria chemoprevention in a specific Nigerian region.
Study design
Researchers conducted a retrospective, descriptive evaluation utilizing aggregated routine clinical reporting systems and logistical supply chain records.
Population and setting
The cohort comprised pediatric patients younger than five years attending health facilities across three designated administrative districts in Plateau State during the mid-year to autumn months of 2024.
Main findings
Clinical records documented nearly ten thousand febrile presentations with universal diagnostic screening. Parasite detection rates fluctuated between thirty-nine and sixty-eight percent, demonstrating a gradual reduction from late spring to early autumn. Supply chain logs confirmed extensive medication dispensing without inventory disruptions, yet diagnostic confirmation rates remained elevated throughout the intervention window.
Public-health relevance
Routine monitoring highlights persistent diagnostic confirmation rates alongside widespread intervention coverage, indicating a need for enhanced programmatic tracking and periodic efficacy assessments.
Important limitations
The authors explicitly caution that aggregated routine metrics cannot independently verify pharmacological effectiveness or emerging pathogen resistance. Furthermore, this assessment depends exclusively on the provided abstract and bibliographic details, requiring access to the complete manuscript for rigorous methodological validation.
GIDS interpretation
This article offers regional epidemiological insights into pediatric chemoprevention implementation and routine diagnostic utilization. It may assist investigators exploring local healthcare delivery patterns and intervention coverage metrics within comparable tropical environments.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 10 auditable classifier relationships to diseases, places, topics, and study design.